Close Menu
Home » NHGRI Awards $14.5M to Developers of '$1,000 Genome' Sequencing Techs

NHGRI Awards $14.5M to Developers of '$1,000 Genome' Sequencing Techs

Aug 23, 2011
Premium

By Julia Karow

The National Human Genome Research Institute has awarded about $14.5 million in grants to nine research groups developing new DNA sequencing technologies to sequence a human genome for $1,000 or less.

Seven of the grants went to academic groups — one with ties to Oxford Nanopore Technologies — and two were awarded to companies, Stratos Genomics and Electron Optica.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Making a Mark

A new analysis founds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Optimistic, Though Cautious

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

And Maybe a Fee

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

Nature Highlights Study Finding Differences in Infant Gut Microbiome by Delivery Mode, More

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

What's Popular?

In Clinical Sequencing

  1. ACLA Urges FDA to Reconsider Recent PGx Enforcement Moves

  2. Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring

  3. Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.